European Archives - Page 1577 of 1585 - European Medical Journal

EMJ Diabetes 2013

Along with up-to-date, peer-reviewed papers and interesting new developments in the world of diabetes, outside of the 2013 EASD Congress. This issue…

Is it Time to Transform our Treatment of Type 2 Diabetes?

This meeting comprised two sessions: the morning session centred around glucagon-like peptide-1 receptor (GLP-1R) agonists and SGLT-2 inhibitors, a new…

Diabetes Mellitus and Periodontitis: Signs of a Bidirectional Relationship

Periodontitis is a multifactorial, irreversible and cumulative condition, initiated and propagated by bacteria and host factors. The multifactorial…

Ambulatory Blood Pressure Monitoring and Circadian Rhythm of Blood Pressure in Diabetes Mellitus

Systolic and diastolic blood pressures display a circadian rhythmicity that can be assessed by 24-hour ambulatory blood pressure monitoring and analysed…

Mortality in Patients with Pad with Respect to Glycaemic Status: A Review

Peripheral arterial disease (PAD) is a manifestation of atherosclerosis. Atherosclerosis is a chronic inflammatory process and nonenzymatic glycation is…

Oligodendrogenesis After Cerebral Ischaemia and Traumatic Brain Injury

Stroke and traumatic brain injury (TBI) damage white and grey matter. Loss of oligodendrocytes and their myelin, impairs axonal function.

Mode of Delivery in Multiple Sclerosis

Multiple sclerosis (MS) is a chronic immune-mediated disorder of the central nervous system, affecting women of childbearing age. Little is known about…

Neurorehabilitation After Stroke

Recovery from ischaemic stroke is determined in the acute phase by the lesion impact of ischaemia and subsequently, by functional and structural network…

Current Essentials in Inflammatory Myopathies

Inflammatory myopathies are a heterogeneous group of acquired systemic diseases, which include dermatomyositis (DM), polymyositis (PM), necrotising…

Fertility Preservation Options for Cancer Patients

Survival rates for cancer patients have increased in the last few years due to improvements achieved in cancer therapies.